CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism. This evidence concerns the gene CDK9 and precursor B-cell acute lymphoblastic leukemia.